-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Guardant Health, Raises Price Target to $120

Benzinga·12/15/2025 18:19:54
Listen to the news
Wells Fargo analyst Brandon Couillard maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $93 to $120.